Esperion

Quote




Yes I call it Clamoring parties. Playing games with my district called Pin the Tail on RD. They look similar also. Now back to fielding questions from my territory. This launch is a monster.
 




This is so damn sweet. I LUV Esperion and their fat cash. It’s very generous indeed. word out that all bonus to be paid at target rate at the very minimum for balance of year. Thank you gentlemen.
 








anonymous said:
Honestly I just got hired a couple weeks ago and I feel like I hit the jackpot/won the lottery. No work get paid so much. It’s crazy!
Click to expand...
Enjoy it while it lasts, bro....Someone, sooner or later, will ask serious questions where all that money went without any return on investment! And that “someone” will get a bad answer and will be pissed!
 




If you follow the talk with investors on Wall Street with the stock down in the 30's from a high of 86 and 70 on 2/19 Esperion is primed to be bought. It's a bargain right now with stock so low and an salesforce in limbo that can be cut with no strings attached and company absorbed into Big Pharma. Regardless of the new person on Executive Committee Esperion needs a life preserver fast. No money coming to speak of and the launch won't hit prior expectations at 80.00 per share . That's how it happens guys. In fairness you've been given an incredible two to three month vacation.
 




anonymous said:
If you follow the talk with investors on Wall Street with the stock down in the 30's from a high of 86 and 70 on 2/19 Esperion is primed to be bought. It's a bargain right now with stock so low and an salesforce in limbo that can be cut with no strings attached and company absorbed into Big Pharma. Regardless of the new person on Executive Committee Esperion needs a life preserver fast. No money coming to speak of and the launch won't hit prior expectations at 80.00 per share . That's how it happens guys. In fairness you've been given an incredible two to three month vacation.
Click to expand...
There is a lot of garbage on this site, but this poster is spot on!
 




anonymous said:
This is so damn sweet. I LUV Esperion and their fat cash. It’s very generous indeed. word out that all bonus to be paid at target rate at the very minimum for balance of year. Thank you gentlemen.
Click to expand...

Esperion is Radius Health of a couple years ago. Radius also had tons of cash until their product launch crashed and burned and so did most of the sales force. Oh and Radius hired a lot less reps than Esperion?
 




anonymous said:
Esperion is Radius Health of a couple years ago. Radius also had tons of cash until their product launch crashed and burned and so did most of the sales force. Oh and Radius hired a lot less reps than Esperion?
Click to expand...

If this product and company was so great a big pharma company would takeover esperion with the stock price so low. Esperion has hired way too many reps at way too high a salary and now with a several month delay launching this company with probably end of floundering like Radius did but only time will tell.
 




anonymous said:
If this product and company was so great a big pharma company would takeover esperion with the stock price so low. Esperion has hired way too many reps at way too high a salary and now with a several month delay launching this company with probably end of floundering like Radius did but only time will tell.
Click to expand...

If you look at the CEO's slides, the launch is modeled after Janssen's Xarelto launch.
And BA comes no where close to the impact that Xarelto had.
 




anonymous said:
If you look at the CEO's slides, the launch is modeled after Janssen's Xarelto launch.
And BA comes no where close to the impact that Xarelto had.
Click to expand...

Gee why not use the lipitor model or the viagra model? what a joke!! The pharma environment is terrible for launching almost everything so good luck with BA!!
 








anonymous said:
If this product and company was so great a big pharma company would takeover esperion with the stock price so low. Esperion has hired way too many reps at way too high a salary and now with a several month delay launching this company with probably end of floundering like Radius did but only time will tell.
Click to expand...

First of all they would never retain the Esperion reps, RD's VP' . They would dump them and there salaries. The drug would go into their brands and they would already have a much lower paying sales team to sell it..90 % of the Esperion team bombed out in there last jobs. Look at their rankings and % to quota at former employers. same with the RD's. This can be a niche drug in a big pharma company. Right now shareholders in Esperion would take 45.00 a share right now to get out.
 




anonymous said:
First of all they would never retain the Esperion reps, RD's VP' . They would dump them and there salaries. The drug would go into their brands and they would already have a much lower paying sales team to sell it..90 % of the Esperion team bombed out in there last jobs. Look at their rankings and % to quota at former employers. same with the RD's. This can be a niche drug in a big pharma company. Right now shareholders in Esperion would take 45.00 a share right now to get out.
Click to expand...

I think it will be below 20 in a year. They will get a “pass” for the next 2-3 quarters. I think by early 2021 it will painfully obvious that the sales of this product will be woefully shy of projections. I’m trying to remember, in the northern hemisphere does a toilet swirl clockwise or counter-clockwise? Either way, it’s going down the drain.
 




It was in upper 20's last week. Its staying around 35-38 right now. There should've been a bump up yesterday but it didnt move. This drug is in trouble. They won't survive the summer. No investment firm is going to throw them a bone with everything going on in the world to help a generic Zetia drop LDL's 17% . That's the reality.
 








Team, please lets not get too discouraged by all this mayhem. We've been delayed, and that's all.
We will launch, and it will be excellent when we do. Don't be put off by the weapon of politics that are being use. CDC says annual hospitalization rates are up to 75-80,000 a year, with 60-65,000 deaths. This isn't that much different. We will get through this. BA will be available to patients who need to lover their LDL-C's to reduce incidence of potential future events. We've got the drug to do it!

All stock prices are getting hit right now, not just ESPR. We'll bounce back just like everyone else. Remain positive. We will succeed. MD's are counting on us to bring these life-saving drugs to their patients. They know we're the lipid experts, and we need to continue upping our game to make sure we are the tops in the industry-who they can rely on for the best drug and the best information. Stay focused. Stay positive. We will win.

CB
 




Ok CB how come other stocks are going up. Boeing is up to 180 from 100 a week ago and that company had a fork on it. Investors think Esperion is flaccid. Its marked as a sell stock right now . What does that tell you ??? This isn't a novel game changing medication. No outcomes ! Low reductions and it cost too much. Managed care is going to crucify this drug. After the PCSK9 debacles where arrogance got in the way of common sense Esperion is headed that way. Just read what CB said . It smells of arrogance and incompetence. Lipid experts ? With the team you've got in place I don't think so. Most were in bottom ranking of % to goal and couldn't generate any volume . Do you really think doctors are going to open up their access restrictions just for BA. Nope! Won't happen. People get resumes in order. Your going to hear the RD's yell soon "everyman for himself"
 




anonymous said:
Team, please lets not get too discouraged by all this mayhem. We've been delayed, and that's all.
We will launch, and it will be excellent when we do. Don't be put off by the weapon of politics that are being use. CDC says annual hospitalization rates are up to 75-80,000 a year, with 60-65,000 deaths. This isn't that much different. We will get through this. BA will be available to patients who need to lover their LDL-C's to reduce incidence of potential future events. We've got the drug to do it!

All stock prices are getting hit right now, not just ESPR. We'll bounce back just like everyone else. Remain positive. We will succeed. MD's are counting on us to bring these life-saving drugs to their patients. They know we're the lipid experts, and we need to continue upping our game to make sure we are the tops in the industry-who they can rely on for the best drug and the best information. Stay focused. Stay positive. We will win.

CB
Click to expand...

You stupid ignorant idiot. The Covid19 numbers are on top of the regular issues hospitals have to deal with that is the problem you stupid fucking moron. Yes the CV community is in desperate need of your BA with zeita giving a huge 17-20% decrease in LDL. (That was sarcasm just in case you missed it) What a joke your product and your company is and will be, just sell to big pharma and end the charade.
 




How many thousands of scripts were written this week?!? Bahaha!!! I love the people hoping for big pharma to step in and purchase esperion. It’s at a billion dollar market cap... assuming the purchase the stock at a 50% premium, why in gods name would big pharma pay 1.5 billion for a drug that won’t even do 1.5 billion, TOTAL, over the first five years?!? Interviewing with Amarin and BMS; either one will feel like dodging a Bullet. The good news is I won’t be competing with the guy the hired over me. Who is going to hire someone that is leaving after 2 months?!?
 




Top Bottom
Back
Quote